Share：
Share this content in WeChat
X
[Chinese][PDF]86692
• Review •
Arrhythmogenic right ventricular cardiomyopathy: cardiovascular magnetic resonance update
CHENG Sai-nan  ZHAO Shi-hua 

DOI:10.12015/issn.1674-8034.2016.04.014.


[Abstract] Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a frequent cause of sudden death in the young. Since 1970s, many imaging centers have accumulated much more experience. The purpose of this paper is to provide an overall review of the definition, cardiomyopathy classification update, diagnosis and especially cardiovascular magnetic resonance update on ARVC.
[Keywords] Arrhythmia；Cardiomyopathy；Magnetic resonance imaging；Cardiovascular magnetic resonance

CHENG Sai-nan Department of Cardiac MR, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China

ZHAO Shi-hua* Department of Cardiac MR, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China

*Correspondence to: Zhao SH, E-mail: cjr.zhaoshihua2009@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of key projects of National Natural Science Foundation of China No. 81130029
Received  2016-01-20
Accepted  2016-03-08
DOI: 10.12015/issn.1674-8034.2016.04.014
DOI:10.12015/issn.1674-8034.2016.04.014.

[1]
Pilichou K, Nava A, Basso C, et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation, 2006, 113(9): 1171-1179.
[2]
Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace, 2011, 13(8): 1077-1109.
[3]
Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J, 2015, 36(41): 2793-2867.
[4]
Cristina Basso, Domenico Corrado, Frank I Marcus, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet, 2009, 373(9671): 1289-1300.
[5]
程怀兵，赵世华．致心律失常性右室心肌病的心血管磁共振成像研究进展. 国际医学放射学杂志, 2011, 34(3): 240-245.
[6]
Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation, 1996, 93(5): 841-842.
[7]
Maron BJ, Towbin JA. Contemporary definitions and classification of the cardiomyopathies. Circulation, 2006, 113(14): 1807-1816.
[8]
Perry Elliott, Bert Andersson, Eloisa Arbustini, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J, 2008, 29(2): 270-276.
[9]
Arbustini E, Narulay N, Dec GW, et al. The MOGE(S) classification for a phenotypeeGenotype nomenclature of cardiomyopathy. Glob Heart, 2013, 8(4): 355-382.
[10]
Arbustini E, Narula N, Dec GW, et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol, 2013, 62(22): 2046-2072.
[11]
McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J, 1994, 71(3): 215-218.
[12]
Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation, 2010, 121(13): 1533-1541.
[13]
Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J, 2010, 31(7): 806-814.
[14]
张兆琪, 马晓海. 从ARVC/D诊断标准的变迁看MRI对致心律不齐性右室型心肌病的诊断价值．磁共振成像, 2010, 1(5): 334-336.
[15]
Vermes E, Strohm O, Otmani A, et al. Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. JACC Cardiovasc Imaging, 2011, 4(3): 282-287.
[16]
te Riele AS, Tandri H, Bluemke DA. Arrhythmogenic right ventricular cardiomyopathy: cardiovascular magnetic resonance update. J Cardiovasc Magn Reson, 2014, 16(1): 50.
[17]
Burt JR, Zimmerman SL, Kamel IR, et al. Myocardial T1 mapping: techniques and potential applications. Radiographics, 2014, 34(2): 377-395.
[18]
陈秀玉, 赵世华. 心血管磁共振临床应用及进展. 磁共振成像, 2015, 6(2): 86-90.
[19]
陆敏杰, 赵世华, 蒋世良, 等. MR纵向弛豫时间定量成像评价肥厚型心肌病心肌纤维化的初步研究．中华放射学杂志, 2013, 47(5): 391-395.
[20]
Bluemke DA. Progress in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia by cardiac magnetic resonance imaging using feature tracking. Circ Cardiovasc Imaging, 2015, 8(11): 4167.
[21]
Vigneault DM, Te Riele AS, James CA, et al. Right ventricular strain by MR quantitatively identifies regional dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy. J Magn Reson Imaging, 2015, DOI: 10.1002/jmri.25068.
[22]
Groenink M, Wilde AA. The "accordion sign" a new tune in arrhythmogenic right ventricular dysplasia/cardiomyopathy magnetic resonance imaging?. J Am Coll Cardiol, 2009, 53(15): 1300-1301.
[23]
Dalal D, Tandri H, Judge DP, et al. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol, 2009, 53(15): 1289-1299.
[24]
Tandri H, Macedo R, Calkins H, et al. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Am Heart J, 2008, 155(1): 147-153.
[25]
Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol, 2005, 45(1): 98-103.
[26]
Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol, 1997, 30(6): 1512-1520.
[27]
Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol, 2008, 52(25): 2175-2187.
[28]
Rastegar N, Zimmerman SL, te Riele AS, et al. Spectrum of biventricular involvement on CMR among carriers of ARVD/C-associated mutations. JACC Cardiovasc Imaging, 2015, 8(7): 863-864.
[29]
Sen-Chowdhry S, Syrris P, Ward D, et al. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation, 2007, 115(13): 1710-1720.
[30]
Etoom Y, Govindapillai S, Hamilton R, et al. Importance of CMR within the Task Force Criteria for the diagnosis of ARVC in children and adolescents. J Am Coll Cardiol, 2015, 65(10): 987-995.
[31]
Gomes J, Finlay M, Ahmed AK, et al. Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study. Eur Heart J, 2012, 33(15): 1942-1953.
[32]
te Riele AS, Bhonsale A, James CA, et al. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol, 2013, 62(19): 1761-1769.
[33]
Baumwart RD, Meurs KM, Raman SV. Magnetic resonance imaging of right ventricular morphology and function in boxer dogs with arrhythmogenic right ventricular cardiomyopathy. J Vet Intern Med, 2009, 23(2): 271-274.
[34]
Lopez-Ayala JM, Oliva-Sandoval MJ, Sanchez-Muñoz JJ, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet, 2015, 385(9968): 662.
[35]
Turrini P, Corrado D, Basso C, et al. Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation, 2001, 103(25): 3075-3080.
[36]
Ma N, Cheng H, Lu M, et al. Cardiac magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy: correlation to the QRS dispersion. Magn Reson Imaging, 2012, 30(10): 1454-1460.
[37]
Cheng HB, Lu MJ, Hou CH, et al. Comparative study of CMR characteristics between arrhythmogenic right ventricular cardiomyopathy patients with/without syncope. Int J Cardiovasc Imaging, 2014, 30(7): 1365-1372.

PREV A review of the application of MRI techniques in cognitive impairment after traumatic brain injury
NEXT The correlation between multi-parametric MRI of prostate imaging reporting and data system score and transrectal ultrasound guided needle biopsy
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn